Basic Information
Basic information for FTX-202-34aa
Peptide Name FTX-202-34aa
Genome Position chrX:74203060-74203161[-]
Species Human
Peptide Sequence MSTGQSWIRKFLQIRLGKQGLDPSCLWTKTNHHF
Peptide Length 34
Unique No (FTX-210-34aa-2,FTX-218-34aa,FTX-223-34aa,FTX-224-34aa,FTX-228-34aa,FTX-229-34aa,FTX-231-34aa,FTX-233-34aa,FTX-236-34aa,FTX-238-34aa,FTX-241-34aa,FTX-245-34aa,FTX-257-34aa,FTX-261-34aa,FTX-264-34aa,FTX-265-34aa,FTX-266-34aa,FTX-268-34aa)
Grand Average of Hydropathicity -0.5735
Relative Molecular Mass 4610.26
Experimental Evidences 1:m6A
lncRNA ID/Name ENSG00000230590;FTX
Transcript ID/Name ENST00000423992;FTX-202
Transcript Length 1997
Coding Ability 0.5914
DNA Sequence Corresponding to Peptide ATGTCTACAGGGCAATCATGGATCAGGAAATTTCTGCAAATTAGACTTGGAAAACAAGGTCTTGATCCTTCTTGTCTTTGGACGAAGACTAATCATCACTTT
Experimental Evidences
   m6A
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :